To the Editor: Long-term use of benzodiazepines has been associated with advancing age, female gender, depression, and use of more than two other prescription drugs [1] [2] [3] . Discontinuing benzodiazepines may improve body stability and daytime cognition without causing distressing withdrawal symptoms or emergent sleep difficulties [4] [5] [6] . The objective of this study was to investigate benzodiazepine discontinuation in the municipality of Leppävirta in eastern Finland from 2006 to 2008.
The study sample comprised all community-dwelling people aged ≥65 years (n=2415) in Leppävirta on 31 August 2006. Records of reimbursed drug purchases for 2006-2008 were extracted from the Finnish National Prescription Register maintained by the Social Insurance Institution (SII) of Finland [7] . Drugs were categorized using the Anatomical Therapeutic Chemical classification system. Benzodiazepines were defined as anxiolytics (N05B) and hypnotics and sedatives (N05C), which included zopiclone, zolpidem, and zaleplon (N05CF). Patient diagnoses were extracted from the Special Reimbursement Register maintained by the SII. Diagnoses included endocrine disorders (diabetes, hypothyroidism), mental and neurological disorders (depression, epilepsy, psychosis, Alzheimer's disease, Parkinson's disease), cardiovascular disease (heart failure, hypertension, coronary artery disease, arrhythmias), respiratory disease (chronic asthma, chronic obstructive pulmonary disease), and musculoskeletal disorders (connective tissue disease, rheumatoid arthritis). Benzodiazepine use at baseline was defined as receipt of one or more prescriptions for benzodiazepines in the 6 months until 31 August 2006. Benzodiazepine use at follow-up was defined as receipt of one or more prescriptions for benzodiazepines in the 6 months until 31 August 2008. Logistic regression was used to investigate factors associated with benzodiazepine discontinuation between baseline and follow-up. Forty-six percent of benzodiazepine users in 2006 were categorized as nonusers at the 2-year follow-up, with benzodiazepine discontinuation associated age 85+years. The high rate of discontinuation among the oldest age category is encouraging because previous studies have reported that increasing age is associated with long-term benzodiazepine use [1, 2] . Unlike in previous studies, female sex, mental or neurological disorders, and use of other prescription drugs were not associated with long-term use [1] [2] [3] . A strength of the study was that the Prescription Register included all reimbursed drug purchases for all residents in noninstitutional settings. However, not all brands of small packs of benzodiazepines we reimbursed by the SII [8] . In conclusion, our results challenge the popular misconception that discontinuation is too difficult among people aged 85+ years. 
